Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Quantifying TNFR1 in both soluble and membrane bound form using AlphaLISA technology
membrane-bound1920x640
Technical Note

Quantifying TNFR1 in both soluble and membrane bound form using AlphaLISA technology

Quantitative Assessment of Soluble TNFR1 Using the Human TNFR1 AlphaLISA ™ Kit.

This technical note provides additional evidence of the kit’s capabilities by detecting sTNFR1 in cell supernatant and in the cell membrane. It also shows you how easily the human TNFR1 AlphaLISA™ detection kit quantifies and measures soluble TNFR1 in serum and cell culture media.

For research use only. Not for use in diagnostic procedures.

Download Resource

Quantifying TNFR1 in both soluble and membrane bound form using AlphaLISA technology

Download Technical Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.